Cargando…
LDOC1 as Negative Prognostic Marker for Vulvar Cancer Patients
So far, studies about targeted therapies and predictive biomarkers for vulva carcinomas are rare. The leucine zipper downregulated in cancer 1 gene (LDOC1) has been identified in various carcinomas as a tumor-relevant protein influencing patients’ survival and prognosis. Due to the lack of informati...
Autores principales: | Wanka, Giulia, Schmoeckel, Elisa, Mayr, Doris, Fuerst, Sophie, Kuhn, Christina, Mahner, Sven, Knabl, Julia, Karsten, Maria Margarete, Dannecker, Christian, Heidegger, Helene H., Vattai, Aurelia, Jeschke, Udo, Jueckstock, Julia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7730493/ https://www.ncbi.nlm.nih.gov/pubmed/33291445 http://dx.doi.org/10.3390/ijms21239287 |
Ejemplares similares
-
MTA1 as negative prognostic marker in vulvar carcinoma
por: Wanka, Giulia, et al.
Publicado: (2023) -
Combined COX-2/PPARγ Expression as Independent Negative Prognosticator for Vulvar Cancer Patients
por: Ansorge, Nadine, et al.
Publicado: (2021) -
EP4 as a Negative Prognostic Factor in Patients with Vulvar Cancer
por: Buchholz, Anna, et al.
Publicado: (2021) -
Regulatory T Cells with Additional COX-2 Expression Are Independent Negative Prognosticators for Vulvar Cancer Patients
por: Ansorge, Nadine, et al.
Publicado: (2022) -
Prostaglandin E2 receptor EP1 expression in vulvar cancer
por: Buchholz, Anna, et al.
Publicado: (2022)